Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Idealized line source configuration for permanent 125I prostate implants.

Ghyslain Leclerc1, Marie-Claude Lavallée, Dragan Tubic

  • 1Département de radio-oncologie et Centre de recherche en cancérologie, Centre Hospitalier Universitaire de Québec, Pavillon Hôtel-Dieu, 11 Côte du Palais, Québec, QC, Canada, G1R 2J6.

Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|August 7, 2004
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

High-performance dosimetric gel for low-dose-rate 3D-printed brachytherapy devices.

Physics in medicine and biology·2026
Same author

Metformin modifies hormone changes associated with androgen deprivation therapy for prostate cancer.

Endocrine oncology (Bristol, England)·2026
Same author

Pelvic nodes ultra-hypo fractionated versus conventionally fractionated IMRT with HDR brachytherapy in prostate cancer: interim analysis of a collaborative multi-institutional non-inferiority phase 3 trial (PCS-XI, NCT05820633).

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2026
Same author

Platform for the Evaluation of innovations in Radiation oncology through registry-based conduct of multi-centric pragmatic randomized trials: PERa implementation.

Trials·2026
Same author

Assessing inter-observer variability in prostate and GTV segmentation on mpMRI: A comparison between radiation oncologists and AI-based method.

Journal of applied clinical medical physics·2026
Same author

Robust external-beam calibration of plastic scintillation detectors and uncertainty analysis for<i>in-vivo</i>dosimetry in HDR brachytherapy.

Physics in medicine and biology·2026

Idealized seed orientations accurately approximate real ones for permanent 125I prostate implant dosimetry. This validation supports using simplified seed configurations for reliable post-implant dose calculations in prostate cancer treatment.

Area of Science:

  • Medical Physics
  • Radiation Oncology
  • Nuclear Medicine

Background:

  • Permanent 125I prostate implants are a standard treatment for localized prostate cancer.
  • Accurate post-implant dosimetry is crucial for optimizing treatment efficacy and minimizing toxicity.
  • Current dosimetry methods can be complex, necessitating exploration of simplified approaches.

Purpose of the Study:

  • To validate the use of idealized seed orientations with line source formalism for post-implant dosimetry.
  • To assess the dosimetric impact of using simplified seed configurations compared to actual seed orientations.
  • To determine if this approach is suitable for reporting dose coverage in prostate and organs at risk.

Main Methods:

  • CT and fluoroscopic images were acquired for 32 patients post-implant.

Related Experiment Videos

  • Individual seed positions and orientations (phi, theta) were determined for 1625 seeds.
  • Dosimetric calculations were performed using both real and idealized seed orientations.
  • Main Results:

    • Angular distributions of seeds showed general similarity between real and idealized orientations.
    • Dose-volume histograms and key dosimetric parameters revealed no significant differences.
    • The D90 for the prostate differed by only 0.02%, with slightly larger variations in organs at risk.

    Conclusions:

    • Idealized seed orientations can be reliably used with line source formalism for dosimetry.
    • This simplified approach provides accurate dose coverage reporting for prostate and surrounding organs.
    • The findings support the clinical application of idealized seed configurations in permanent 125I prostate brachytherapy.